Skip to content

Prognostic Differences Between Macrotrabecular and Non-Macrotrabecular Hepatocellular Carcinoma: Comparative Analysis of Therapeutic Efficacy Following Surgical Resection

Prognostic Differences Between Macrotrabecular and Non-Macrotrabecular Hepatocellular Carcinoma: Comparative Analysis of Therapeutic Efficacy Following Surgical Resection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500103101
Enrollment
Unknown
Registered
2025-05-23
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma (HCC)

Interventions

The group of Macrotrabecular Hepatocellular Carcinoma:NA
The group of Non-Macrotrabecular Hepatocellular Carcinoma:NA

Sponsors

The First Affiliated Hospital of Xi'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patients who strictly met the clinical diagnostic criteria for hepatocellular carcinoma (HCC) or were definitively diagnosed with HCC through histopathological or cytological examination. 2. Availability of well-preserved histopathological slides with definitive pathological classification. 3. Child-Pugh class A or B liver function classification; 4. Patients aged 18-85 years; 5. After surgical resection of hepatocellular carcinoma (HCC).

Exclusion criteria

Exclusion criteria: 1. Have received prior systemic therapy or surgical treatment for liver cancer; 2. History of or current diagnosis of a primary malignant tumor other than hepatocellular carcinoma (HCC); 3. no regular physical examination, laboratory examination or imaging examination (abdominal CT) during the follow-up period; 4. Unable to extract enough data. 5. Pregnant or lactating women;

Design outcomes

Primary

MeasureTime frame
overall survival;

Secondary

MeasureTime frame
Progression-free survival;early recurrence;

Countries

China

Contacts

Public ContactXin Zheng

The First Affiliated Hospital of Xi'an Jiaotong University

zhengxin@xjtufh.edu.cn+86 29 8532 3215

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 26, 2026